Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimally Invasive Interval Debulking Surgery in Ovarian Cancer

NCT03378128 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03378128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimally Invasive Interval Debulking Surgery in Ovarian Cancer
Lead sponsor
Case Comprehensive Cancer Center
Phase
Not applicable
Overall status
Completed
Start date
January 12, 2018
Completion date
April 30, 2020
Enrollment
50 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasm of fallopian tube, malignant neoplasm of ovary, malignant neoplasm of peritoneum